The major pre-market indexes ��the Dow Jones industrial average, Standard & Poor's 500 and Nasdaq ��all rose around 0.1% before the opening bell.
The U.S. stock market lost ground Thursday as electronics retailer Best Buy, Goldman Sachs and Citigroup, and railroad CSX had disappointing earnings news.
The S&P 500 index slipped 0.1% to 1,845.89, the Dow fell 0.4% to 16,417.01 and the Nasdaq composite had a modest gain of 0.1% to 4,218.69.
THURSDAY: Big stock drops rock Wall Street
Most Asian markets declined Friday following the retreat in Wall Street. Japan's Nikkei 225 dipped 0.1% to 15,734.46 and China's Shanghai composite index sank 0.6% to 2,004.95.
Benchmark crude for February delivery added 13 cents to $94.09 in electronic trading at the New York Merchantile Exchange. The contract fell 21 cents to settle at $93.96 on Thursday.
Top 5 Machinery Stocks To Buy Right Now: R.R. Donnelley & Sons Company(RRD)
R.R. Donnelley & Sons Company provides pre-media, printing, logistics, and business process outsourcing products and services to private and public sectors worldwide. The company operates primarily in the commercial print portion of the printing industry, with related product and service offerings designed to offer customers solutions for communicating their messages to target audiences. Its products and related service offerings include magazines, catalogs, retail inserts, books, directories, financial print, direct mail, forms, labels, office products, statement printing, pre media, and logistics services. The company also offers business process outsourcing services that comprise transactional print and outsourcing services, statement printing, direct mail, and print management services; and product configuration, customized kitting, and order fulfillment for technology, medical device, and other companies. It distributes its products to end-users through the United Sta tes postal services, retail channels, electronically, or by direct shipment to customer facilities. R.R. Donnelley & Sons was founded in 1864 and is based in Chicago, Illinois.
Advisors' Opinion:- [By Selena Maranjian]
Commercial printer R.R. Donnelley (NASDAQ: RRD ) , also up 28%, yields 7.3%. It sells labels, packaging, and more to the private and public sector and prints many thousands of forms for the SEC, too. Donnelley bought Edgar Online last year. Some have worried about the company's debt load, though it is free-cash-flow positive. (But it has posted net losses in recent years, too.) The company needs to do more digital business to succeed, which explains a recent eBook deal with Harlequin.
- [By Dan Burrows]
R.R. Donnelley (RRD)
RRD Price/LFCF: 9.4
RRD Dividend Yield: 6.7%It’s hard to find a more boring company than R.R. Donnelley (RRD). It both prints and creates custom content (e.g., annual reports) for private and public companies.
- [By John Udovich]
Printing and the various forms of marketing communications that need to be printed (like business cards and stationary) are fundamental to the needs of every business, meaning the recent share surge of small cap Standard Register Co (NYSE: SR) after it announced an acquisition along with its long-term performance against better known peers like RR Donnelley & Sons Co (NASDAQ: RRD) and VistaPrint Limited (NASDAQ: VPRT) is worth taking a closer look at. After all, Standard Register is up 363.2% since the start of the year verses a return of 113.4% for RR Donnelley & Sons Co and�75.9% for VistaPrint Limited.
- [By Selena Maranjian]
Among holdings in which Caxton Associates increased its stake was R. R. Donnelley (NASDAQ: RRD ) . Commercial printer Donnelley provides labels, packaging, and more to the private and public sector. It prints many thousands of forms for the SEC, too, and bought Edgar Online. Bears worry about its steep debt load, though the company is free-cash-flow positive. Some also worry about a possible reduction of its dividend, which recently yielded nearly 8%. To succeed, the company needs to do more digital business. To that end, it recently sealed an eBook deal with Harlequin.
Top 10 Diversified Bank Stocks For 2014: NxStage Medical Inc.(NXTM)
NxStage Medical, Inc., a medical device company, develops, manufactures, and markets products for the treatment of kidney failure, fluid overload, and related blood treatments and procedures. Its primary product, the NxStage System One, is a portable hemodialysis system used for home hemodialysis and a range of dialysis therapies for chronic home hemodialysis treatment, and the treatment of acute kidney failure and fluid overload. The NxStage System One comprises components, such as The NxStage Cycler, a compact portable electromechanical device; The NxStage Cartridge, a single-use integrated treatment cartridge; and premixed dialysate for hemodialysis applications. The company also sells a line of extracorporeal disposable products for use primarily for in-center dialysis treatments for patients with end-stage renal disease (ESRD); and needles and blood tubing sets primarily to dialysis clinics for the treatment of ESRD. NxStage Medical, Inc. markets its products primaril y to dialysis clinics, nephrologists, and hospitals through distributors and sales representatives in the United States, Mexico, and Europe. The company was formerly known as QB Medical, Inc. and changed its name to NxStage Medical, Inc. NxStage Medical, Inc. founded in 1998 and is headquartered in Lawrence, Massachusetts.
Advisors' Opinion:- [By John Udovich]
Small cap dialysis stock Rockwell Medical Inc (NASDAQ: RMTI) looks set to decline when the market opens after Brean Capital initiated coverage with a sell rating and a price target of $4.00, meaning it might be time to take a closer look at what is going on with the stock along with�the performance of large cap dialysis stocks DaVita Healthcare Partners (NYSE: DVA)�and Fresenius Medical Care (NYSE: FMS) along with small cap dialysis stocks NxStage Medical, Inc (NASDAQ: NXTM).�
Top 10 Diversified Bank Stocks For 2014: Kimberly-Clark Corporation(KMB)
Kimberly-Clark Corporation, together with its subsidiaries, engages in the manufacture and marketing of various health care products worldwide. The company operates in four segments: Personal Care, Consumer Tissue, K-C Professional & Other, and Health Care. The Personal Care segment provides disposable diapers, training and youth pants, and swimpants; baby wipes; and feminine and incontinence care products, and related products. It offers its products primarily for household use under various brand names, including Huggies, Pull-Ups, Little Swimmers, GoodNites, Kotex, Lightdays, Depend, and Poise. The Consumer Tissue segment offers facial and bathroom tissue, paper towels, napkins, and related products for household use under the Kleenex, Scott, Cottonelle, Viva, Andrex, Scottex, Hakle, and Page brands. The K-C Professional & Other segment offers facial and bathroom tissue, paper towels, napkins, wipers, and a range of safety products for the away-from-home marketplace und er Kimberly-Clark, Kleenex, Scott, WypAll, Kimtech, KleenGuard, Kimcare, and Jackson brand names. The Health Care segment offers disposable health care products, such as surgical drapes and gowns, infection control products, face masks, exam gloves, respiratory products, pain management products, and other disposable medical products under the Kimberly-Clark, Ballard, and ON-Q brand names. The company sells its products to supermarkets; mass merchandisers; drugstores; warehouse clubs; variety and department stores; retail outlets; manufacturing, lodging, office building, food service, and health care establishments; and high volume public facilities. It markets its products through wholesalers, distributors, and direct sales. The company was founded in 1872 and is based in Dallas, Texas.
Advisors' Opinion:- [By Sean Williams]
But I knew better, and so did many investors who saw P&G hardly budge following each warning.
For starters, P&G's problems weren't solely related to P&G -- they were sectorwide. Church & Dwight (NYSE: CHD ) , for instance, operates globally and was forced to lower its forecast last year after consumers began buying larger amounts of lower-margin items, and following a pricing war with P&G in the laundry detergent aisle. Kimberly-Clark (NYSE: KMB ) , the maker of Huggies diapers and Kleenex tissues, struggled as well with foreign currency translation, having $55 million in full-year profits evaporate because of an unfavorable exchange rate. The point is this was a sectorwide struggle, not just a P&G problem.
The P&G advantage
Whereas some view P&G's glass as half empty, P&G ran with this weakness as an opportunity to regain market share and further fortify its brand image. Over the past couple of quarters, it's done this through a number of key initiatives. - [By Shauna O'Brien]
Kimberly Clark Corp (KMB) reported higher first quarter earnings on Monday, which came in above analysts’ views.
KMB’s Earnings in Brief
KMB posted Q1 earnings of�$538 million, or $1.41 per share, up from $531 million, or $1.36 per share, a year ago. Excluding special items, earnings were $1.48 per share, above analysts’ estimate of $1.47 per share. Revenue fell to�$5.278 billion from $5.318 billion reported last year and missed analysts’ estimate of $5.32 billion. Looking forward, KMB expects to see FY2014 earnings between�$6.00 and $6.20 per share, while analysts expect to see $6.11 per share in earnings.CEO Commentary
CEO and chairman Thomas J. Falk�commented: “We delivered a solid first quarter with good organic sales growth and cost savings.� We also launched a number of product innovations and made further progress with targeted growth initiatives.� We continue to allocate capital in shareholder-friendly ways, as our first quarter dividends and share repurchases totaled three-quarters of a billion dollars.� And although we face continued headwinds from currency exchange rates and cost inflation, we’re maintaining our full-year guidance for adjusted earnings per share.� We continue to be optimistic about the opportunities we have to drive profitable growth and generate attractive returns to shareholders.”
KMB’s Dividend
KMB paid its last 84 cent dividend on April 2. We expect the company to declare its next dividend in May.
Stock Performance
Kimberly Clark shares were up 71 cents, or 0.63%, during pre-market trading Monday. The stock is up 7.74% YTD.
KMB Dividend SnapshotAs of Market Close on April 17, 2014
Click here to see the complete history of KMB dividends.
Top 10 Diversified Bank Stocks For 2014: Ametek Inc (AME)
AMETEK, Inc. (AMETEK), incorporated in 1930, is a global manufacturer of electronic instruments and electromechanical devices with operations in North America, Europe, Asia and South America. The Company markets its products worldwide through two groups: the Electronic Instruments Group (EIG) and the Electromechanical Group (EMG). EIG builds monitoring, testing, calibration and display devices for the process, aerospace, industrial, power and medical markets. EMG produces engineered electromechanical connectors for hermetic (moisture-proof) applications, specialty metals for niche markets and brushless air-moving motors, blowers and heat exchangers. End markets include aerospace, defense, mass transit, medical, office products and other industrial markets. In December 2013, the Company announced that it has acquired Powervar, a provider of power management systems and uninterruptible power supply (UPS) systems. In January 2014, the Company acquired Teseq Group. In February 2014, the Company acquired VTI Instruments.
The Electronic Instruments Group
EIG consists of a group of differentiated businesses. EIG manufactures instruments used for testing, monitoring, calibration and display for the process, aerospace, industrial and power markets. EIG is specialized in the markets it serves, including aerospace engine sensors, heavy-vehicle instrument panels, analytical instrumentation, level measurement products, power instruments and pressure gauges. It has joint venture operations in China, Taiwan and Japan. EIG had 56 operating facilities: 35 in the United States, seven in the United Kingdom, five in Germany, three in France, two in Switzerland and one each in Argentina, Austria, Canada and Denmark, as of December 31, 2011. EIG also shares operating facilities with EMG in China and Mexico.
Process and analytical measurement and analysis instruments include oxygen, moisture, combustion and liquid analyzers; emission monitors; spectrometers; mechanical and electronic ! pressure sensors and transmitters; radiation measurement devices; level measurement devices; precision pumping systems, and force-measurement and materials testing instrumentation. EIG�� focus is on the process industries, including oil, gas and petrochemical refining, power generation, specialty gas production, water and waste treatment, natural gas distribution and semiconductor manufacturing. AMETEK�� analytical instruments are also used for precision measurement in a number of other applications including radiation detection for the United States Department of Homeland Security, materials analysis, nanotechnology research and other test and measurement applications.
TMC serves the manufacturers of life sciences, photonics and semiconductor equipment with a range of custom active piezoelectric vibration cancellation systems, based on their patented active piezo technology. TMC also supplies passive vibration cancellation systems, optical test tables, acoustic isolation hoods and magnetic isolation hoods. Reichert Technologies provides high-technology instruments used by ophthalmologists, optometrists, and opticians for vision correction and the screening and diagnosis of eye diseases, such as glaucoma and macular degeneration.
Atlas Material Testing Technology LLC (Atlas) has products, which include weather exposure test systems, corrosion-testing instruments, specialty lighting systems, and large-scale weathering test chambers. In addition, Atlas offers indoor laboratory and outdoor testing services, photovoltaic and solar testing and consulting. AMETEK�� power businesses provide analytical instruments, uninterruptible power supply systems and programmable power supplies used in a range of industrial settings. EIG designs and manufactures power measurement and recording instrumentation used by the electric power and manufacturing industries. Those products include power transducers and meters, event and transient recorders, annunciators and alarm monitoring systems us! ed to mea! sure, monitor and record variables in the transmission and distribution of electric power.
EIG�� Solidstate Controls business designs and manufactures uninterruptible power supply systems for the process and power generation industries. EIG also manufactures sensor systems for land-based gas turbines and for boilers and burners used by the utility, petrochemical, process and marine industries worldwide. EIG�� programmable power business provides programmable alternating current (AC) and direct current (DC) power sources. EM Test provides equipment used to perform electrical immunity and electromagnetic compatibility testing. EM Test manufactures a full line of conducted electromagnetic compatibility test equipment, including electrical fast transient generators, electrostatic discharge simulators, surge generators, waveform simulators and multifunctional generators.
Aerospace products include airborne data systems; turbine engine temperature measurement products; vibration-monitoring systems; indicators; displays; fuel and fluid measurement products; sensors; switches; cable harnesses, and transducers. EIG serves all segments of commercial aerospace, including helicopters, business jets, commuter aircraft and commercial airliners, as well as the military market. Its customers are the producers of airframes and jet engines and other aerospace system integrators. The Company also serves the commercial aerospace aftermarket with spare part sales and repair and overhaul services.
Electromechanical Group
EMG provides engineered motors, blowers, fans, heat exchangers, connectors, and other electromechanical products or systems for commercial and military aerospace applications, defense, medical equipment, business machines, computers and other power or industrial applications. EMG had 58 operating facilities: 34 in the United States, nine in the United Kingdom, three in France, two each in China, Czech Republic, Italy and Mexico and one each in Brazil, M! alaysia, ! Morocco and Taiwan, as of December 31, 2011. Differentiated businesses consists of the technical motors and systems businesses and the engineered materials, interconnects and packaging businesses. Technical motors and systems consist of brushless motors, blowers and pumps, as well as other electromechanical systems. These products are used in aerospace and defense, business machines, computer equipment, mass transit vehicles, medical equipment, power, and industrial applications.
EMG produces electronically commutated (brushless) motors, blowers and pumps. These motor-blower systems and heat exchangers are used for thermal management and other applications on a range of military and commercial aircraft and military ground vehicles, and are used in medical and other applications. These motors provide cooling and ventilation for business machines, computers and mass transit vehicles. EMG also serves the commercial and military aerospace third-party maintenance, repair and overhaul (MRO) market. These services are provided on a global basis with facilities in the United States, Europe and Singapore.
During the year ended December 31, 2011, engineered materials, interconnects and packaging products represented 37% of EMG�� net sales. AMETEK provides specialized metal powder, strip, wire and bonded products. It produces stainless steel and nickel clad alloys; stainless steel, cobalt and nickel alloy powders; metal strip; specialty shaped and electronic wire, and advanced metal matrix composites used in electronic thermal management. Its products are used in automotive, appliance, medical and surgical, aerospace, telecommunications, marine and general industrial applications.
Coining provides custom-shaped preforms, microstampings and wire used for joining electronic circuitry, packaging microelectronics and providing thermal protection and electric conductivity for a range of electronic devices. Coining�� products are used in engineered applications for the radio f! requency ! (RF)/microwave, photonics, medical, aerospace and defense, and general electronics industries. Avicenna produces fine-featured catheter and other medical components for leads, guide wires and custom medical assemblies. Avicenna complements the Company�� medical device market businesses fits with its Technical Services for Electronics (TSE) business. TSE fits with the HCC Industries division, which manufactures engineered electronic interconnects and microelectronics packaging for sophisticated electronic applications.
AMETEK is a medical interconnects provider with integrated capabilities for the catheter, cardiac and neurostimulation markets. During 2011, floorcare and specialty motor markets represented 18% of EMG�� net sales, where it sells air-moving electric motors to the floorcare other equipment manufacturers (OEMs), including vertically integrated OEMs that produce some of their own motors. EMG produces motor-blowers for a range of floorcare products, ranging from hand-held, canister and upright vacuums to central vacuums for residential use. High-performance vacuum motors also are marketed for commercial and industrial applications.
The Company also manufactures a variety of specialty motors used in a range of products, such as household and personal care appliances; fitness equipment; electric materials handling vehicles, and sewing machines. In addition, its products are used in outdoor power equipment, such as electric chain saws, leaf blowers, string trimmers and power washers.
Advisors' Opinion:- [By Monica Gerson]
Zygo (NASDAQ: ZIGO) shares gained 31.06% to touch a new 52-week high of $19.24 after Ametek (NYSE: AME) announced its plans to buy Zygo for about $364 million.
- [By Gregory Vousvounis]
Ametek (AME) is a global manufacturer of electronic instruments and electromechanical devices. Ametek is a strong leader in most of its niche markets having either a low-cost advantage over competitors or higher-quality products that address critical customer needs.
- [By John Udovich]
Last week, it was reported that S&P MidCap 400 constituents Vertex Pharmaceuticals (NASD: VRTX) and Ametek Inc (NYSE: AME) would be replacing Advanced Micro Devices (NYSE: AMD) and SAIC Inc (NYSE: SAI) in the S&P 500, and Advanced Micro Devices and SAIC will replace Vertex Pharmaceuticals and Ametek in the S&P Mid Cap 400. I should mention that both Advanced Micro Devices and SAIC Inc are�in our�SmallCap Network Elite Opportunity (SCN EO) portfolio and as of today, we are down 1.29% and up 19.77%, respectively, in both stocks. In the case of�Advanced Micro Devices, we feel the company�� transition into mobility and gaming consoles makes it a compelling value while defense contractor SAIC Inc is interesting as its well positioned to address�cyber security issues. Moreover, SAIC Inc is splitting into 2 companies in a transaction that�� expected to be completed before the end of the month.
Top 10 Diversified Bank Stocks For 2014: Syntroleum Corporation(SYNM)
Syntroleum Corporation and its subsidiaries engage in commercializing and licensing its Syntroleum technologies to produce synthetic liquid hydrocarbons. Its Syntroleum process involves conversion of carbon containing material into synthesis gas; and conversion of the synthesis gas or coal-derived or biomass-derived syngas into hydrocarbons. The company also develops the Synfining Process technology for the conversion of Fischer-Tropsch wax into various products, including diesel fuels, jet fuels, lubricants, naphtha, and other materials. In addition, it offers the Bio-Synfining technology, a second generation renewable fuels technology that is feedstock flexible, including the use of vegetable oils, fats, fatty acids, and greases. Syntroleum Corporation was founded in 1984 and is based in Tulsa, Oklahoma.
Advisors' Opinion:- [By John Udovich]
Small cap biofuel or synthetic fuel stocks Gevo, Inc (NASDAQ: GEVO), KiOR Inc (NASDAQ: KIOR), Solazyme Inc (NASDAQ: SZYM) and Syntroleum Corp (NASDAQ: SYNM) all seem to have been seeing some trading action in recent days���meaning its worth taking a closer look at all four�before taking a look at their rather dismal�long term performance while noting that none are yet profitable:
- [By John Udovich]
As a new Government Accountability Office (GAO) report comes out about wasteful spending on biofuels, small cap renewable biofuel stock Gevo, Inc (NASDAQ: GEVO) reported earnings that came in below expectations -�meaning its worth taking a closer look at the GAO report, the stock and the performance of KiOR Inc (NASDAQ: KIOR), Solazyme Inc (NASDAQ: SZYM) and Syntroleum Corp (NASDAQ: SYNM).
Top 10 Diversified Bank Stocks For 2014: Rofin-Sinar Technologies Inc (RSI)
Rofin-Sinar Technologies Inc., incorporated on July 19, 1996, is engaged in the designing, development, engineering, manufacturing and marketing of laser-based products used for cutting, welding and marking a range of materials. The Company offers a range of laser products and related services for three material processing applications: cutting, welding, and surface treatment (macro applications); marking, and fine cutting, fine welding, micro drilling, and micro structuring (micro applications). It provides a range of laser sources and laser-based system solutions to markets, such as the machine tool, automotive, semiconductor, electronics, and photovoltaic industries. Its product categories include Laser macro products, Laser marking products, Laser micro products and Components. The products are sold directly to end-users and to original equipment manufacturers (OEMs).
As of September 30, 2013, the Company had over 4,000 customers (including multinational companies with multiple facilities purchasing from the Company). During the year ended September 30, 2013 (fiscal 2013), approximately 38%, of the Company�� revenues related to sales of laser products for macro applications, approximately 13%, related to sales of components, and approximately 49%, related to sales of laser products for marking and micro applications.
LASER MACRO PRODUCTS
The Company�� carbon dioxide laser products for macro applications consist of DC Slab Series, SC Series, XL Series, STS Series, FH Series and SM Series. Its XL, STS, FH and SM Series fast-axial flow carbon dioxide lasers are used for both cutting and welding applications and are marketed under the PRC and NELC brand. XL, STS, FH, SM, FA, and PLS Series products are used primarily by the machine tool industry. Its SC Series diffusion cooled, wave-guide carbon dioxide lasers are developed and produced by Rofin-Sinar UK Ltd. The SC Series are sealed-off lasers, used for cutting and structuring applications. Markets for the! se include machine tool, electronics, and packaging industries. The Company�� DQ Series of Q switched, solid-state lasers are designed for applications, such as removal, cleaning and insulation of various materials in the automotive, consumer electronics and photovoltaic markets. The Company�� FL Series of high-brightness single or multi-mode fiber lasers use fiber optics as the active medium. These fiber lasers are used for cutting and welding applications, as well as for new applications, such as remote cutting. Its diode lasers are designed to meet the requirements of a range of welding, soldering and surface treatment applications.
LASER MARKING PRODUCTS
Rofin offers standardized and customized laser marking systems in different power ranges and wavelengths for use in various industrial segments. The Company�� standard PowerLine marking products consist of a range of lasers with output power from 2 watts to 100 watts with a galvo-head, a personal computer with processor, and Rofin�� VisualLaserMarker software. Special options and accessories include a double marking head allowing speeds of up to 1,600 characters per second in certain applications, as well as beam-switching and -splitting options for marking of products in multiple production lines using a single laser. It is used in the semiconductor and electronics industries. MultiScan vector scanning marker utilizes a 100 watts sealed-off carbon dioxide laser. It is used in marking of consumer goods in the packaging industry. LabelMarker Advanced is a laser-based system is Rofin�� solution. This laser system is used in any production area without additional safety requirements. The EasyMark is a transportable desktop device. The EasyMark offers a program-controlled z-axis and a rotary axis, which can optionally be integrated. An aluminum T-slot plate facilitates mounting of customer-specific work piece carriers. The EasyJewel is a transportable desktop device developed to mark jewellery. CombiLine Cube/CombiLi! ne Advanc! ed compact laser workstations have been designed for small and medium-size batches. NuQ pulsed fiber laser sources are produced and marketed under the Nufern brand and are designed for OEM customers and integrators.
LASER MICRO PRODUCTS
The Company markets and sells a range of laser products, including, pulsed, fiber and other solid-state lasers for various spot welding and fine cutting applications; carbon dioxide Slab lasers for perforating applications; Q switched, solid-state lasers for surface structuring, and diode lasers for soldering and plastic welding applications. The Company's manual welders for micro applications, which are sold under the name Performance Tool Open and Internal, consist of pulsed, solid-state lasers in the range of 60 watts to 200 watts, which are primarily used for fine welding applications in the medical device, jewelry and mold making industries. The StarPulse Series consists of pulsed Nd:YAG rod lasers with power ratings from 40 to 500 watts. These are designed for use in fine welding applications, such as laser welding of reflective materials in the medical device and electronics industry.
The StarFiber Series achieve nominal powers of 100 watts up to 600 watts. The lasers can be operated in either pulse-modulated or continuous wave mode. The StarFiber Series is designed for a range of applications for fine welding and fine cutting, such as welding of electromechanic components or fine cutting. The X-Lase Series consists of picosecond pulse mode-locked fiber laser systems with an output power of upto 24 watts. Markets are in the semiconductor, electronics and display industries. In these industries, the X-Lase products can be used for thin film patterning, ablation and scribing applications. Its StarFemto Series consists of femtosecond pulse mode-locked laser systems with a maximal output power of 5 watts. Main markets are medical implants and other fine cutting or structuring applications. The PerfoLas Systems consist of a carbo! n dioxide! laser in combination with a galvo scanning head and is used for precise cutting, drilling, and surface structuring.
The Universal Workstation (UW) and Modular Processing System (MPS) Series are modular laser-based systems that are designed to meet a variety of applications, including welding, cutting, surface modification and ablation. Depending on the application, the UW and MPS Systems can be equipped with different laser sources (femtosecond, fiber, diode, or solid-state laser) and modified for specific handlings. Series 800 are flash-lamp pumped, solid-state lasers sold to OEM customers, and system integrators for various micro and marking applications. Series LDP and LEP are diode pumped, solid-state lasers sold to OEM customers and system integrators for various micro and marking applications. Series LDPP are diode pulse-pumped Nd:YAG lasers that are designed to cut thin metals. Market is the medical devices industry. Series LFP are hybrid diode pumped, solid state, picosecond lasers that are produced and marketed under the Lee Laser brand and are sold to OEM customers and system integrators for various micro applications.
The COMPACT and MINI Diode Laser System Series are laser systems are available in a range of output powers and wavelengths, including fiber-coupled direct beam or line source solutions, and are engineered for utilization in industrial laser materials processing, mainly for plastic welding, soldering and brazing applications in the automotive, medical device and electronic industries. The KLS Series lasers are pulsed solid-state lasers which are used for fine cutting, drilling and scribing applications. The FLS Series are lamp pumped, pulsed, solid-state lasers with high peak power for deep penetration cutting, welding and drilling. SLS CL Series are pulsed Nd:YAG solid-state lasers with output powers in the range of 5 to 250 watts. The KLS 246, FLS, LFS and SLS CL Series are all manufactured by the Company's Switzerland-based subsidiary LASAG.
COMP! ONENT PRODUCTS
The Company offers power supplies for pulsed and continuous wave solid-state lasers, carbon dioxide lasers, diode lasers, as well as radio frequency (RF) generators for acousto-optic Q-switches through its wholly owned subsidiary PMB Elektronik GmbH. Fiber and Optics Technology are special fiber lasers, fiber coupling products and optical engines, for use in fiber lasers are manufactured and marketed by the Company�� Finland-based subsidiary Corelase Oy. Laser Diodes and Modules are high-power semiconductor components, such as high power, high-brightness laser diodes and modules are manufactured and marketed by the Company�� subsidiaries Dilas Diodenlaser GmbH, Dilas Diodelaser Inc., Dilas Diodelaser China and m2k-laser GmbH. Fibers, fiber components, beam splitters or switches and beam combiners designed for use in industrial lasers or as beam delivery systems are manufactured and marketed by Optoskand AB. Fibers and fiber laser technology components are developed, manufactured and marketed by Nufern, East Granby. The Company�� high-technology components are either integrated by other laser manufacturers into their products or are used for the Company�� own product portfolio.
The Company competes with Trumpf, GSI Group, Unitek Miyachi, Han's Laser, Fanuc, Synrad, Coherent, IPG, Laserline and Jenoptik.
Advisors' Opinion:- [By Joon Choi]
Currently, the monthly relative strength indicator (RSI) reading is 83.7. (A reading over 70 is considered to be overbought.) To put this figure in perspective, the monthly RSI of the Nasdaq Composite was 85.9 on March of 2000 (the index peak), and we know what happened afterwards.
- [By Greg Harmon]
The Fresh Market (TFM), has been rising off of a bottom in March. It recently went through a 'W' consolidation and jumped higher, but is now retesting the top of the 'W'. The relative strength index (RSI) has held the mid line during the pullback and remains bullish while the moving average convergence divergence indicator (MACD) is not as positive. A turn higher, back over 53.50 could be a catalyst for a long entry, but a fall under 52 sets a target for a measured move (MM) lower to 50. This stock does not report earnings until late August.
Top 10 Diversified Bank Stocks For 2014: Roche Holding AG (RHHBY)
Roche Holding AG is a Switzerland-based pharmaceuticals and diagnostics company. The Company belongs to the Roche Group that operates through numerous subsidiaries and associated companies located around the world. The Company�� products and services cover every stage of the healthcare process, from identifying disease susceptibilities and testing for disease in at-risk populations to prevention, diagnosis, therapy and treatment monitoring. Roche operates through two divisions: Pharmaceuticals and Diagnostics. Within the Pharmaceuticals Division there are three sub-divisions: Roche Pharmaceuticals, Genentech and Chugai. The Company�� Diagnostics Division includes five sub-divisions: Applied Science, Diabetes Care, Molecular Diagnostics, Tissue Diagnosis and Professional Diagnostics. Its activities are structured into six geographical segments: North America; Asia-Pacific; Western Europe; Latin America; Central and Eastern Europe, Middle East and Africa (CEMAI), and Japan. In March 2009, the Company completed the acquisition of Genentech, Inc. In March 2010, the Company acquired assets from BioMicro Systems for all products associated with the Roche NimbleGen microarray workflow.
During the year ended December 31, 2008, the Company Pharmaceuticals Division marketing gained approvals for its rheumatoid arthritis medicine Actemra/RoActemra in Japan, Switzerland and the European Union. In 2008, the division initiated 12 new phase III projects in, including clinical trials of the compounds pertuzumab, for breast cancer; taspoglutide, for type two diabetes, and dalcetrapib, for cardiovascular risk reduction. As of December 31, 2008, the Pharmaceuticals Division filed 11 major new marketing applications and gained 13 major regulatory approvals. At the beginning of 2009, the division�� research and development pipeline comprised 120 clinical projects, including 62 new molecular entities (NMEs) and 58 additional indications. Forty NMEs are in phase I, 16 in phase II and six in phase III or f! iled for regulatory review.
In 2008, Roche Pharmaceuticals signed a total of 57 new agreements including seven product transactions and 43 research and technology collaborations. In May 2008, Roche acquired Piramed Limited, a UK company with therapeutic research programmes targeting the PI3-kinase pathway in oncology and inflammatory disease. In June 2008, signed licensing agreement with ThromboGenics and BioInvent for their jointly developed anticancer agent TB-403 (R7334). In September, 2008, the Company acquired Mirus Bio Corporation active in the field of ribonucleic acid interference (RNAi) delivery and completed the acquisition of ARIUS Research Inc., which has a antibody platform that identifies and selects antibodies based on their functional ability to affect disease. S Research Inc. In January 2009, Roche acquired Memory Pharmaceuticals, which develops drug candidates for the treatment of debilitating central nervous system disorders such as Alzheimer�� disease and schizophrenia.
Pharmaceuticals
Within Pharmaceuticals division, the Company is engaged in the provision of drugs the areas of oncology, anemia, cardiovascular diseases, central nervous system, infectious diseases, inflammatory and autoimmune diseases, metabolic disorders, cancer, transplantation and virology. The products offered by Roche�� Pharmaceuticals division include MabThera/Rituxan, Herceptin, Avastin, Tamiflu, CellCept, NeoRecormon, Epogin, Pegasys, Tarceva, Xeloda, Bonviva, Boniva, Lucentis, Tamiflu, Xolair, Valcyte, Cymevene, Xenical, Pulmozyme, Nutropin, Neutrogin, Rocephin, Activase, TNKase and Madopar. The products offered by the Pharmaceuticals division are sold in seven geographic regions: North America; Asia-Pacific; Western Europe; Latin America; Central and Eastern Europe, Middle East and Africa (CEMAI), and Japan.
Diagnostics
Roche�� Diagnostics Division is a supplier of in vitro diagnostics (IVDs). Its products are used to test body fluids a! nd tissue! samples to obtain information for the purpose of preventing, diagnosing, treating and monitoring disease. The Company has business areas five within the diagnostics division: Professional Diagnostics, Diabetes Care, Tissue Diagnostics, Molecular Diagnostics and Applied Science. Roche�� Diagnostics division provides IVD services, including centralized laboratory testing and point-of-care diagnostics to molecular diagnostics and diabetes self management. In addition, it supplies research tools to life scientists.
Roche Professional Diagnostics supplies instrument systems, tests, software and services. It provides point-of-care testing products to support clinical decision-making close to the patient, in doctors��offices, emergency rooms and other primary and specialty care settings. Twelve Serum Work Area assays were rolled out during the year ended December 31, 2008, across Europe and in other markets. New assays included the Elecsys anti-TSH receptor antibody assay for the diagnosis of Graves��disease the Elecsys anti-CCP antibody assay, a test to aid the diagnosis of rheumatoid arthritis, and the Roche Cystatin C clinical chemistry test for early detection of impaired kidney function, among others. Roche Diabetes Care�� products portfolio covers the entire diabetes self-management spectrum, from glucose monitoring to insulin delivery, as well as monitoring systems with integrated lancets and test strips software for storing and analyzing data. Roche Tissue Diagnostics develops and manufactures medical diagnostic instruments and reagent systems that provide automation technology for use in the diagnosis and prognosis of cancer and infectious disease. In 2008 Roche Tissue Diagnostics launched ofhe Bench- Mark Ultra, a system that performs immunohistochemistry and in situ hybridisation testing simultaneously on a single continuous and random access platform. Roche Molecular Diagnostics develops and commercializes diagnostic and blood screening platforms and tests based on Roche�� ! real-time! polymerase chain reaction (PCR) technology. Applied Science business area supplies a specific reagents and test kits for use in life sciences encompassing biology, biotechnology ,medical research, as well as disease areas like cancer and virology. Applied Science�� business area product portfolio includes such sequencing systems as LightCycler 480, LightCycler 480 II, GS FLX Titanium. In addition, Applied Science offers xCELLigence cell analyzer.
Advisors' Opinion:- [By Leo Sun]
In September 2013, Roche (NASDAQOTH: RHHBY ) made an up-front payment of $10 million to Inovio, along with agreeing to milestone payments up to $412.5 million, for exclusive licenses on two vaccines -- INO-5150 for prostate cancer and INO-1800 for hepatitis B. The deal also entitled Inovio to double-digit tiered royalties on future sales of the products. But Roche ended the licensing agreement for INO-5150 in November, eliminating a large portion of those potential milestone and royalty payments. Roche will stick with INO-1800 and launch a phase 1/2a study in early 2015, but it could also walk away there if the results disappoint.
- [By Sean Williams]
So what: It's been a miserable day for Allergan, which started the day off by slightly lowering its full-year EPS forecast from a range of $4.75-$4.83 to $4.70-$4.76. To add the icing on the cake, its midday report that DARPin did show some differentiation from Novartis (NYSE: NVS ) and Roche's (NASDAQOTH: RHHBY ) Lucentis but didn't demonstrate enough to move the drug onto phase 3 trials, sent Allergan into the abyss. It probably doesn't help, either, that MAP's inhaled migraine drug Levadex, which Allergan acquired when it purchased MAP for nearly $1 billion earlier this year, also recently received its second complete response letter. Allergan just can't seem to catch a break.
- [By James E. Brumley]
When an investor thinks of an immunology stock, it's usually a name like Amgen, Inc. (NASDAQ:AMGN) or Roche Holding Ltd. (OTCMKTS:RHHBY) that comes to mind. Amgen has shown promising success with a melanoma treatment based on the science of immunotherapy, while Roche has made headway in the world of lung cancer using the same idea. Bigger, however, is not always better. Indeed, in the world of biotechnology development, the quality of an idea for a new drug is the key. That's how a little name like TNI Biotech Inc. (OTCMKTS:TNIB) could end up standing shoulder to shoulder with giants like RHHBY or AMGN. TNIB is capitalizing on one of the many nuances of immunotherapy, yet that one small tweak could end up being a huge breakthrough.
- [By James Brumley]
Ditto for the gene-mapping mania that was sparked by the Roche (RHHBY) acquisition of Illumina and the GlaxoSmithKline (GSK) purchase of Human Genome Sciences. By the time the gene-mapping M&A trend became obviously hot, the trend was over.
No comments:
Post a Comment